Lipoprotein metabolism and lipid management in chronic kidney disease.
Kwan
Bonnie C H
BC
Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
Kronenberg
Florian
F
Beddhu
Srinivasan
S
Cheung
Alfred K
AK
D000975:Antioxidants / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000209:etiology; D002908:Chronic Disease; D050171:Dyslipidemias / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D007674:Kidney Diseases / Q000150:complications / Q000378:metabolism*; D008074:Lipoproteins / Q000737:chemistry / Q000378:metabolism*; D009525:Niacin / Q000627:therapeutic use; D006435:Renal Dialysis
D000975:Antioxidants; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008074:Lipoproteins; D009525:Niacin